Type I IFN-mediated enhancement of anti-leukemic cytotoxicity of γδ T cells expanded from peripheral blood cells by stimulation with zoledronate

Cytotherapy

Volumn 8, Issue 2, 2006, Pages 118-129

  Watanabe, N ^a   Narita, M ^a   Yokoyama, A ^a   Sekiguchi, A ^a   Saito, A ^a   Tochiki, N ^a   Furukawa, T ^b   Toba, K ^b   Aizawa, Y ^b   Takahashi, Masuhiro ^a  

^a NIIGATA UNIVERSITY   (Japan)

^b NIIGATA UNIVERSITY GRADUATE SCHOOL OF MEDICAL AND DENTAL SCIENCES   (Japan)

Author keywords

T cells; Anti leukemic cytotoxicity; Type I IFN; Zoledronate

Indexed keywords

ALPHA2B INTERFERON; BETA INTERFERON; BISPHOSPHONIC ACID DERIVATIVE; CD69 ANTIGEN; CHROMIUM 51; GAMMA INTERFERON; INTERFERON; INTERLEUKIN 2; MONOCLONAL ANTIBODY; ZOLEDRONIC ACID;

ANTIGEN EXPRESSION; ARTICLE; CANCER IMMUNOTHERAPY; CELL ASSAY; CHROMIUM 51 RELEASE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DRUG MECHANISM; FLOW CYTOMETRY; HEMATOLOGIC MALIGNANCY; HUMAN; HUMAN CELL; IN VITRO STUDY; INTERFERON PRODUCTION; LEUKEMIA CELL; LYMPHATIC LEUKEMIA; LYMPHOCYTE CULTURE; LYMPHOMA; MYELOID LEUKEMIA; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PURIFICATION; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION;

ANTIGENS, CD; ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE; CELL PROLIFERATION; CELLS, CULTURED; CYTOTOXICITY, IMMUNOLOGIC; DIPHOSPHONATES; DOSE-RESPONSE RELATIONSHIP, IMMUNOLOGIC; HUMANS; IMIDAZOLES; IMMUNOTHERAPY, ADOPTIVE; INTERFERON TYPE I; INTERFERON TYPE II; INTERLEUKIN-2; LEUKOCYTES, MONONUCLEAR; LYMPHOCYTE ACTIVATION; RECEPTORS, ANTIGEN, T-CELL, GAMMA-DELTA; T-LYMPHOCYTES; TUMOR CELLS, CULTURED;

EID: 33646387194     PISSN: 14653249     EISSN: None     Source Type: Journal    
DOI: 10.1080/14653240600620200     Document Type: Article

References (23)

1. Carding, SR and Egan, PJ. (2002) Gammadelta T cells: Functional plasticity and heterogeneity Nat Rev Immunol, 2, pp. 336-45.
2. Tanaka, Y and Morita, CT and Tanaka, Y and (1995) Natural and synthetic non-peptide antigens recognized by human gamma delta T cells Nature, 375, pp. 155-8.
3. Bukowski, JF and Morita, CT and Brenner, MB. (1999) Human gamma delta T cells recognize alkylamines derived from microbes, edible plants, and tea: Implications for innate immunity Immunity, 11, pp. 57-65.
4. Kunzmann, V and Bauer, E and Wilhelm, M. (1999) Gamma/delta T-cell stimulation by pamidronate N Engl J Med, 340, pp. 737-8.
5. Chen, ZW and Letvin, NL. (2003) Adaptive immune response of Vgamma2Vdelta2 T cells: A new paradigm Trends Immunol, 24, pp. 213-9.
6. Kunzmann, V and Bauer, E and Feurle, J and (2000) Stimulation of gammadelta T cells by aminobisphosphonates and induction of antiplasma cell activity in multiple myeloma Blood, 96, pp. 384-92.
7. Gober, HJ and Kistowska, M and Angman, L and (2003) Human T cell receptor gammadelta cells recognize endogenous mevalonate metabolites in tumor cells J Exp Med, 197, pp. 163-8.
8. Harwood, HJJr and Alvarez, IM and Noyes, WD and (1991) In vivo regulation of human leukocyte 3-hydroxy-3-methylglutaryl coenzyme A reductase: Increased enzyme protein concentration and catalytic efficiency in human leukemia and lymphoma J Lipid Res, 32, pp. 1237-52.
9. Asslan, R and Pradines, A and Pratx, C and (1999) Epidermal growth factor stimulates 3-hydroxy-3-methylglutaryl-coenzyme A reductase expression via the ErbB-2 pathway in human breast adenocarcinoma cells Biochem Biophys Res Commun, 260, pp. 699-706.
10. Takahashi, M and Narita, M and Ayres, F and (2003) Cytoplasmic expression of EGFP in dendritic cells transfected with in vitro transcribed mRNA or cellular total RNA extracted from EGFP expressing leukemia cells Med Oncol, 20, pp. 335-48.
11. Osman, Y and Narita, M and Ayres, F and (2003) Generation of Ag-specific cytotoxic T lymphocytes by DC transfected with in vitro transcribed influenza virus matrix protein (M1) mRNA Cytotherapy, 5, pp. 161-8.
12. Furukawa, T and Koike, T and Ying, W and (1994) Establishment of a new cell line with the characteristics of a multipotential progenitor from a patient with chronic myelogenous leukemia in early erythroblastic crisis Leukemia, 8, pp. 171-80.
13. Narita, M and Takahashi, M and Liu, A and (2001) Leukemia blast-induced T-cell anergy demonstrated by leukemia-derived dendritic cells in acute myelogenous leukemia Exp Hematol, 29, pp. 709-19.
14. Sato, K and Kimura, S and Segawa, H and (2005) Cytotoxic effects of gammadelta T cells expanded ex vivo by a third generation bisphosphonate for cancer immunotherapy Int J Cancer, 116, pp. 94-9.
15. Dieli, F and Gebbia, N and Poccia, F and (2003) Induction of gammadelta T-lymphocyte effector functions by bisphosphonate zoledronic acid in cancer patients in vivo Blood, 102, pp. 2310-11.
16. Sicard, H and Al Saati, T and Delsol, G and (2001) Synthetic phosphoantigens enhance human Vgamma9Vdelta2 T lymphocytes killing of non-Hodgkin's B lymphoma Mol Med, 7, pp. 711-22.
17. Das, H and Wang, L and Kamath, A and (2001) V(2V(2 T-cell receptor-mediated recognition of aminobisphosphonates Blood, 98, pp. 1616-18.
18. Kabelitz, D and Wesch, D and Pitters, E and (2004) Characterization of tumor reactivity of human V gamma 9V delta 2 gamma delta T cells in vitro and in SCID mice in vivo J Immunol, 173, pp. 6767-76.
19. Kato, Y and Tanaka, Y and Miyagawa, F and (2001) Targeting of tumor cells for human gammadelta T cells by nonpeptide antigens J Immunol, 167, pp. 5092-8.
20. Schilbach, K and Geiselhart, A and Handgretinger, R. (2001) Induction of proliferation and augmented cytotoxicity of gammadelta T lymphocytes by bisphosphonate clodronate Blood, 97, pp. 2917-8.
21. Bukowski, JF and Dascher, CC and Das, H. (2005) Alternative bisphosphonate targets and mechanisms of action Biochem Biophys Res Commun, 328, pp. 746-50.
22. Kunzmann, V and Kretzschmar, E and Herrmann, T and (2004) Polyinosinic-polycytidylic acid-mediated stimulation of human gammadelta T cells via CD11c dendritic cell-derived type I interferons Immunology, 112, pp. 369-77.
23. Rincon-Orozco, B and Kunzmann, V and Wrobel, P and (2005) Activation of Vγ9Vδ2 Tcells by NKG2D J Immunol, 175, pp. 2144-51.